<DOC>
	<DOCNO>NCT00005079</DOCNO>
	<brief_summary>RATIONALE : The timing breast cancer surgery within menstrual cycle may affect outcome . It yet know treatment effective initial final phase menstrual cycle . PURPOSE : Phase III trial determine effect menstrual cycle phase surgery treat premenopausal woman stage I , stage II , stage III breast cancer .</brief_summary>
	<brief_title>Timing Menstrual Cycle Surgery Treating Premenopausal Women With Stage I , Stage II , Stage III Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine timing breast surgery menstrual cycle impact disease recurrence , progression , death among different racial group premenopausal woman stage I , II , III breast cancer . - Determine definitive breast cancer surgery ( e.g. , lumpectomy mastectomy ) perform follicular phase result poor prognosis ( recurrence , disease progression , death ) compare surgery perform midcycle luteal phase patient population . OUTLINE : This multicenter study . Patients undergo either fine needle aspiration concurrently definitive breast surgery ( mastectomy lumpectomy ) needle-directed excisional biopsy follow definitive breast surgery . Patients undergo serum collection hormonal analysis preoperatively , 24 hour post operatively , day 7 14 , 3 month urine collection hormonal analysis begin 24 hour prior surgery continue daily onset next menses . Patients complete 30-minute telephone interview regard medical , family , occupational , reproductive history lifestyle habit ( e.g. , diet , exercise , environmental exposure ) . Beginning 24 hour prior surgery continue onset next menses , patient complete menstrual cycle journal indicate start length menses . Patients undergo mastectomy follow every 3 month 1 year , every 6 month 1 year , annually thereafter . Patients undergo adjuvant therapy follow every 3 month 3 year every 6 month thereafter every 4 month 2 year every 6 month thereafter . PROJECTED ACCRUAL : Approximately 400 patient accrue study within 2.5 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage I , II , III primary breast cancer undergo breast surgery Invasive disease ( e.g. , lobular ductal ) No bilateral disease No distant metastases Premenopausal Regular menses ( amenorrhea 90 day ) without hormone replacement Documented last menstrual period Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : Premenopausal Sex : Female Menopausal status : See Disease Characteristics Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No prior malignancy Not pregnant nursing PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No preoperative chemotherapy Endocrine therapy : No concurrent hormonal replacement therapy No concurrent interruptive oral contraceptive use le 3 month Radiotherapy : Not specify Surgery : See Disease Characteristics No prior hysterectomy and/or bilateral oophorectomy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2003</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
</DOC>